Completion of new facility in San Diego

Proteome Sciences is pleased to announce the completion of installation and setup of equipment in its new US laboratory in San Diego, California. and is therefore now fully operational. The laboratory uses the latest generation Orbitrap Ascend Tribrid mass spectrometry and automated sample preparation platforms that will extend the range of services offered to customers.

This new facility is based in one of the largest biotech hubs in the US - a hub which has had, collectively, investment of $17.2 bn and US National Institute of Health funding of $6bn in 2022/23 - Proteome Sciences' state of the art Laboratory is well placed to serve demand from a growing number of US customers looking to outsource proteomics projects to underpin their drug development programmes. By removing the need to ship samples internationally our services are more attractive to customers from both Pharma and academia alike.

• Ian Pike, President of Proteome Sciences US Inc, commented "I am delighted that we are able to open our doors to serve arguably the world's largest biotechnology hub in California. Providing easier access to our US customers and with innovations including TMTpro 32plex and single cell proteomics (SCP), delivered from both our dedicated laboratories in the US and Europe we are well set to continue our leading role in provision of tools, assays and services in proteomics research as it grows in importance to enhance pharmaceutical research and drug development."